Janney Montgomery Scott’s Revance Therapeutics, Inc. RVNC Stock Holding History

Janney Montgomery Scott’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,010	Closed	-$405K	–	2787
2023 Q2	$405K	Sell	16,010 -2,550	-14%	-$79.4K	﹤0.01%	2023
2023 Q1	$598K	Buy	+18,560	New	+$579K	﹤0.01%	1611
2016 Q1	–	Sell	-8,425	Closed	-$288K	–	1430
2015 Q4	$288K	Sell	8,425 -3,895	-32%	-$135K	0.01%	1075
2015 Q3	$367K	Buy	12,320 +2,970	+32%	+$90.2K	0.01%	964
2015 Q2	$299K	Buy	+9,350	New	+$240K	0.01%	1507
2014 Q3	–	Sell	-8,250	Closed	-$281K	–	2332
2014 Q2	$281K	Sell	8,250 -200	-2%	-$6.27K	0.01%	1674
2014 Q1	$266K	Buy	+8,450	New	+$264K	0.01%	1539

Other funds holding RVNC

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janney Montgomery Scott's RVNC Position: Q3 2023 in Review

Janney Montgomery Scott sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2023, closing a stake of 16,010 shares — an estimated $405K sold.

Janney Montgomery Scott first reported a position in RVNC in Q1 2014 and held it in 7 quarters. The position peaked at $598K in Q1 2023. 186 funds tracked by Wall St. Rank hold RVNC as of Q3 2023.

Janney Montgomery Scott reported no remaining Revance Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
Janney Montgomery Scott sold 16,010 Revance Therapeutics, Inc. shares in Q3 2023, an estimated $405K.
Janney Montgomery Scott first reported a position in Revance Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Janney Montgomery Scott's Revance Therapeutics, Inc. position peaked at $598K in Q1 2023.
186 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2023.

Based on Janney Montgomery Scott's 13F filing for Q3 2023, filed 8 Nov 2023.